Comparison of demographic and clinical characteristics of bipolar Ⅰ disorder and bipolar Ⅱ disorder / 中国心理卫生杂志

Objective:To compare demographic characteristics,clinical characteristics,therapeutic characteris-tics and physiological indicators of patients with bipolar Ⅰ disorder and bipolar Ⅱ disorder.Methods:A total of 381 patients with bipolar disorder(BD)diagnosed by the Diagnostic and Statistical Manual of Mental Disorders 5 th Edi-tion(DSM-5)were selected,including 302 patients with BD-Ⅰ(79.27％),74 patients with BD-Ⅱ(19.42％)and 5 patients with other specific and related disorders(1.31％).Demographic and clinical characteristics were collected with self-designed clinical information questionnaire.Multivariate logistic regression and multivariate linear regres-sion analysis were used for analysis.Results:Compared with patients with BD-Ⅱ,patients with BD-Ⅰ had more risk to have psychotic features(OR=5.75,95％CI:2.82-11.76),longer disease duration,and more repeated transcra-nial magnetic therapy(OR=3.09,95％CI:1.02-9.35),higher uric acid,total cholesterol and high-density lipo-protein.BD-Ⅰ in Han nationality was more common(OR=11.50,95％CI:1.76-75.30),and had lower education level(OR=10.22,95％CI:1.16-89.77),and less family history of psychosis(OR=2.34,95％CI:1.01-5.42).Conclusion:There are significant differences between BD-Ⅰ and BD-Ⅱ in demographic and clinical charac-teristics,treatment status,and physiological indicators,which could provide clues for exploring the pathogenesis of bipolar disorder.

Study Advance in Chemical Compositions and Pharmacological Activities of Ficus Pumila L / 中国药师

Through reviewing the relative literatures at home and abroad in recent years, the research progress in the chemical compositions and pharmacological activities of Ficuspumila L.was summarized.The study situation of flavonoids, terpenoids and carbohydrates et al in Ficuspumila L.was reviewed, and such pharmacological activities as antibacterial, antioxidant, hypoglycemic and anti-tumor of Ficuspumila L.were also evaluated.The modern researches showed Ficuspumila L.could be used for the treatment of intestinal cancer, lymphoma, mammary cancer and esophagus cancer.The review provided scientific basis for the further research and clinical application of Ficuspumila L.